Facebook
X
LinkedIn
Forward
HIV and STI Testing in Substance Use Disorder Treatment Centers
| Registration |
|---|
If you are interested in participating, please email [email protected]. |
Target Audience
Primary care physicians, nurses, mental health professionals, substance use disorder professionals, or clinic staff who support behavioral health services.
Purpose
Led by a panel of behavioral health experts, Behavioral Health ECHO helps participants learn best practices for treating common mental health conditions and connect with peers from around the state to discuss and learn best practices for identifying and treating behavioral health issues. The curriculum is delivered free through case-based learning strategies using videoconferencing technology.
Learning Objectives
- Describe the intersection of substance use disorders (SUD), HIV, and sexually transmitted infections (STIs).
- Explain evidence-based approaches for integrating routine HIV and STI screening into SUD treatment programs.
- Identify strategies to reduce stigma and address implementation barriers.
Speaker
Brandi Steck
District Leader, District 1, Iowa Primary Care Association
Accreditation Statements
- MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS) through the joint providership of Des Moines University Medicine and Health Sciences
(DMU) and the Iowa Primary Care Association. DMU is accredited by IMS to provide continuing medical education for physicians. DMU designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity. - DO: Des Moines University Medicine and Health Sciences (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this activity for a maximum of 1.5 AOA Category 2-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
- Other Healthcare Professionals: This activity is designated for a maximum of 1.5 AMA PRA Category 1 Credit(s)™.
 |  |
Educational Grants
No ineligible company provided financial support for this continuing education activity.
Disclosures
The speaker(s) will disclose if any pharmaceuticals, medical procedures, or devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). The activity director is responsible for determining educational content and selecting speakers.
Relevant to the content of this educational activity, the following individual(s) have no conflict(s) with ineligible companies to disclose.
- Autumn Brunia, DO - Planning Committee Member
- Tiffany Conroy, MSW, LISW - Activity Director and Moderator
- Jon Decker, LMHC - Planning Committee Member
- Bery Engebretsen, MD - Planning Committee Member
- Morgan Friend - Activity Coordinator and Moderator
- Nicole Gastala, MD - Planning Committee Member
- Anasara Henry, DNP, ARNP, PMHNP-BC - Planning Committee Member
- Danielle O'Brien-Day, LMHC, NCC - Planning Committee Member
- Brandi Steck - Speaker
Disclaimer
The information provided in this activity is for continuing education purposes only. It is not a substitute for a healthcare provider's independent medical judgment regarding diagnostic and treatment options for a specific patient's medical condition.
Available Credit
- 1.50 AMA PRA Category 1 Credits™
- 1.50 AOA Category 2A
- 1.50 CE Contact Hour(s)